References
- Greenberger P. Allergic Bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002; 110: 685–692
- Wark P. Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment. Respir Med 2004; 98: 915–923
- Hilliard T, Edwards S, Buchdahl R, Francis J, Rosenthal M, Balfour-Lynn I, Bush A, Davies J. Voriconazole therapy in children with cystic fibrosis. J Cystic Fibrosis 2005; 4: 15–220
- DeShazo R, Chapin K, Swain R. Fungal Sinusitis. N Engl J Med 1997; 337: 54–259
- Shah A, Panchal N, Agarwal A K. Concommitant allergic bronchopulmonary aspergillosis and allergic Aspergillus sinusitis: a review of an uncommon association. Clin Exper Allergy 2001; 31: 1896–1905
- Schubert M. Allergic fungal sinusitis: pathogenesis and management strategies. Drugs 2004; 64: 363–374
- deShazo R, Swain R. Diagnostic criteria for allergic fungal sinusitis. J Allergy Clin Immunol 1995; 96: 4–35
- Shale D J, Faux J A, Lane D J. Trial of Ketokonazole in noninvasive pulmonary aspergillosis. Thorax 1987; 42: 6–31
- Stevens D, Schwartz H, Lee J, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000; 342: 756–762
- Wark P AB, Hensley M J, Saltos N, et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 2003; 111: 952–957
- Herbrecht R, Denning D, Patterson T. Voriconazole versus Amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408–415